Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis Publisher



Roostaei T1, 2, 4, 5, 6, 7, 9, 10, 12, 14, 15, 16, 17, 18, 20, 21, 22 ; Sadaghiani S1, 2, 4, 5, 6, 7, 10, 14, 15, 20 ; Mashhadi R3 ; Falahatian M1, 2, 4, 5, 6, 7, 10, 13 ; Mohamadi E1, 2, 4, 5, 6, 7, 10 ; Javadian N1, 2, 4, 5, 6, 7, 10 ; Nazeri A1, 2, 4, 5, 6, 7, 10, 11, 23 ; Doosti R1, 2, 4, 5, 6, 7, 10 ; Naser Moghadasi A1, 2, 4, 5, 6, 7, 10, 19 ; Owji M1, 2, 4, 5, 6, 7, 10 ; Hashemi Taheri AP8 ; Shakouri Rad A8 ; Azimi A1, 2, 4, 5, 6, 7, 10, 19 ; Voineskos AN9, 12, 16, 17, 21, 22 Show All Authors
Authors
  1. Roostaei T1, 2, 4, 5, 6, 7, 9, 10, 12, 14, 15, 16, 17, 18, 20, 21, 22
  2. Sadaghiani S1, 2, 4, 5, 6, 7, 10, 14, 15, 20
  3. Mashhadi R3
  4. Falahatian M1, 2, 4, 5, 6, 7, 10, 13
  5. Mohamadi E1, 2, 4, 5, 6, 7, 10
  6. Javadian N1, 2, 4, 5, 6, 7, 10
  7. Nazeri A1, 2, 4, 5, 6, 7, 10, 11, 23
  8. Doosti R1, 2, 4, 5, 6, 7, 10
  9. Naser Moghadasi A1, 2, 4, 5, 6, 7, 10, 19
  10. Owji M1, 2, 4, 5, 6, 7, 10
  11. Hashemi Taheri AP8
  12. Shakouri Rad A8
  13. Azimi A1, 2, 4, 5, 6, 7, 10, 19
  14. Voineskos AN9, 12, 16, 17, 21, 22
  15. Nazeri A1, 2, 4, 5, 6, 7, 10, 11, 23
  16. Sahraian MA1, 2, 4, 5, 6, 7, 10, 19

Source: Multiple Sclerosis Journal Published:2019


Abstract

Background: Complement system activation products are present in areas of neuroinflammation, demyelination, and neurodegeneration in brains of patients with multiple sclerosis (MS). C3 is a central element in the activation of complement cascades. A common coding variant in the C3 gene (rs2230199, C3R102G) affects C3 activity. Objectives: To assess the effects of rs2230199 on MS severity using clinical, cognitive, and imaging measures. Methods: In total, 161 relapse-onset MS patients (Expanded Disability Status Scale (EDSS) ≤ 6) underwent physical assessments, cognitive tests (Paced Auditory Serial Addition Test (PASAT), Symbol Digit Modalities Test (SDMT), and California Verbal Learning Test (CVLT)), and magnetic resonance imaging (MRI). Lesion volumes were quantified semi-automatically. Voxel-wise analyses were performed to assess the effects of rs2230199 genotype on gray matter (GM) atrophy (n = 155), white matter (WM) fractional anisotropy (FA; n = 105), and WM magnetization transfer ratio (MTR; n = 90). Results: While rs2230199 minor-allele dosage (C3-102G) showed no significant effect on EDSS and Multiple Sclerosis Functional Composite (MSFC), it was associated with worse cognitive performance (p = 0.02), lower brain parenchymal fraction (p = 0.003), and higher lesion burden (p = 0.02). Moreover, voxel-wise analyses showed lower GM volume in subcortical structures and insula, and lower FA and MTR in several WM areas with higher copies of rs2230199 minor allele. Conclusion: C3-rs2230199 affects white and GM damage as well as cognitive impairment in MS patients. Our findings support a causal role for complement system activity in the pathophysiology of MS. © The Author(s), 2018.
Other Related Docs
8. Immune-Mediated Cognition Impairment in Multiple Sclerosis, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)